WO2021037292A3 - 一种多肽及其应用 - Google Patents
一种多肽及其应用 Download PDFInfo
- Publication number
- WO2021037292A3 WO2021037292A3 PCT/CN2020/123555 CN2020123555W WO2021037292A3 WO 2021037292 A3 WO2021037292 A3 WO 2021037292A3 CN 2020123555 W CN2020123555 W CN 2020123555W WO 2021037292 A3 WO2021037292 A3 WO 2021037292A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fibrosis
- arg
- polypeptide
- cys
- gly
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2020335069A AU2020335069A1 (en) | 2019-08-27 | 2020-10-26 | Polypeptide and use thereof |
GB2201001.1A GB2600592A (en) | 2019-08-27 | 2020-10-26 | Polypeptide and use thereof |
CA3149603A CA3149603A1 (en) | 2019-08-27 | 2020-10-26 | Polypeptide and use thereof |
US17/635,990 US20220281916A1 (en) | 2019-08-27 | 2020-10-26 | Polypeptide and use thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910799291.8A CN110437311B (zh) | 2019-08-27 | 2019-08-27 | 一种多肽及其应用 |
CN201910799291.8 | 2019-08-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2021037292A2 WO2021037292A2 (zh) | 2021-03-04 |
WO2021037292A3 true WO2021037292A3 (zh) | 2021-04-22 |
Family
ID=68437902
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2020/123555 WO2021037292A2 (zh) | 2019-08-27 | 2020-10-26 | 一种多肽及其应用 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20220281916A1 (zh) |
CN (1) | CN110437311B (zh) |
AU (1) | AU2020335069A1 (zh) |
CA (1) | CA3149603A1 (zh) |
GB (1) | GB2600592A (zh) |
WO (1) | WO2021037292A2 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110437311B (zh) * | 2019-08-27 | 2022-05-20 | 南京安吉生物科技有限公司 | 一种多肽及其应用 |
CN116789751B (zh) * | 2023-08-22 | 2023-11-17 | 中国农业大学 | 预防和/或治疗纤维化疾病的多肽及其应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008023336A2 (en) * | 2006-08-22 | 2008-02-28 | Ranbaxy Laboratories Limited | Matrix metalloproteinase inhibitors |
CN102268068A (zh) * | 2011-07-01 | 2011-12-07 | 中国药科大学 | 基质金属蛋白酶-9多肽抑制剂1及其应用 |
CN102268070A (zh) * | 2011-07-01 | 2011-12-07 | 中国药科大学 | 基质金属蛋白酶-9多肽抑制剂2及其应用 |
CN104045718A (zh) * | 2014-07-08 | 2014-09-17 | 南京安吉生物科技有限公司 | 多功能融合多肽及其制备方法和应用 |
CN110437311A (zh) * | 2019-08-27 | 2019-11-12 | 南京安吉生物科技有限公司 | 一种多肽及其应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105713095B (zh) * | 2016-03-14 | 2021-05-07 | 南京安吉生物科技有限公司 | 一种多功能融合多肽及其制备方法和应用 |
CN106860855B (zh) * | 2017-03-01 | 2021-06-11 | 成都惠泰生物医药有限公司 | 多肽及多肽衍生物在预防和治疗纤维化疾病中的应用 |
CN109384830B (zh) * | 2017-08-09 | 2021-12-03 | 成都惠泰生物医药有限公司 | 多肽、多肽片段及其衍生物在防治纤维化疾病中的应用 |
-
2019
- 2019-08-27 CN CN201910799291.8A patent/CN110437311B/zh active Active
-
2020
- 2020-10-26 AU AU2020335069A patent/AU2020335069A1/en active Pending
- 2020-10-26 US US17/635,990 patent/US20220281916A1/en active Pending
- 2020-10-26 GB GB2201001.1A patent/GB2600592A/en active Pending
- 2020-10-26 WO PCT/CN2020/123555 patent/WO2021037292A2/zh active Application Filing
- 2020-10-26 CA CA3149603A patent/CA3149603A1/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008023336A2 (en) * | 2006-08-22 | 2008-02-28 | Ranbaxy Laboratories Limited | Matrix metalloproteinase inhibitors |
CN102268068A (zh) * | 2011-07-01 | 2011-12-07 | 中国药科大学 | 基质金属蛋白酶-9多肽抑制剂1及其应用 |
CN102268070A (zh) * | 2011-07-01 | 2011-12-07 | 中国药科大学 | 基质金属蛋白酶-9多肽抑制剂2及其应用 |
CN104045718A (zh) * | 2014-07-08 | 2014-09-17 | 南京安吉生物科技有限公司 | 多功能融合多肽及其制备方法和应用 |
CN110437311A (zh) * | 2019-08-27 | 2019-11-12 | 南京安吉生物科技有限公司 | 一种多肽及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CA3149603A1 (en) | 2021-03-04 |
AU2020335069A1 (en) | 2022-03-10 |
GB202201001D0 (en) | 2022-03-09 |
WO2021037292A2 (zh) | 2021-03-04 |
CN110437311B (zh) | 2022-05-20 |
GB2600592A (en) | 2022-05-04 |
US20220281916A1 (en) | 2022-09-08 |
CN110437311A (zh) | 2019-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2021037292A3 (zh) | 一种多肽及其应用 | |
US10568938B2 (en) | Mussel adhesive protein product and applications thereof in suppression of skin inflammations | |
WO2002002593A3 (en) | Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof | |
EP3801235A4 (en) | PROCEDURE FOR VISUALIZING BODY SURFACE OF A PATIENT AND DETERMINING COORDINATES OF ECG ELECTRODES DURING NON-INVASIVE ELECTROPHYSIOLOGICAL IMAGING OF THE HEART | |
CN100374093C (zh) | 无柄人工髋关节装置 | |
WO2021037289A3 (zh) | 一种重组融合多肽及其应用 | |
ZA202201828B (en) | Therapeutic fusion proteins | |
Harken | A review of the activities of the thoracic center for the III and IV hospital groups, 160th General Hospital European Theater of Operations, June 10, 1944 to Jan. 1, 1945 | |
WO2021037291A3 (zh) | 具有多功能活性的融合多肽及其应用 | |
US11260111B2 (en) | Mussel adhesive protein product and applications thereof in suppression of skin inflammations | |
WO2020198662A8 (en) | Clec9a-based chimeric protein complexes | |
Weißer | Chirurgenlexikon | |
CN209285708U (zh) | 双极电凝 | |
Abdullaeva | Introduction to biomaterials | |
CN204500945U (zh) | 一体式导流吸引双极电凝钳 | |
CN209461018U (zh) | 一种段间标志点量化的肺段魔方 | |
Zamboni et al. | Hemodynamics and volume changes of the venous system | |
Hashimoto | Double-orifice mitral valve with three papillary muscles | |
Huang et al. | A Method to Facilitate “Nonsticking” of Regular Bipolar Forceps | |
Karami et al. | Burn Escharotomy | |
CN208388857U (zh) | 一种膏药贴结构 | |
CN109248285A (zh) | 一种治疗鼻炎用软膏剂 | |
ITMI991526A0 (it) | Apparecchiatura per determinare ed ablare il volume del tessuto cornea le per correggere le ametropie visive | |
Lakkireddy et al. | Advances in Electrophysiology | |
CN204542828U (zh) | 一种多功能按摩器 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20856111 Country of ref document: EP Kind code of ref document: A2 |
|
ENP | Entry into the national phase |
Ref document number: 202201001 Country of ref document: GB Kind code of ref document: A Free format text: PCT FILING DATE = 20201026 |
|
ENP | Entry into the national phase |
Ref document number: 3149603 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2020335069 Country of ref document: AU Date of ref document: 20201026 Kind code of ref document: A |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 20856111 Country of ref document: EP Kind code of ref document: A2 |